COVID

Refining digital collaboration

Pharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to COVID, the industry had begun moving toward intersecting health and technology. Natalie Yeadon, Co-founder and CEO of Impetus Digital, tells us how COVID has accelerated digital health transformation and made effective virtual collaboration more important than ever. …

Refining digital collaboration Read More »

Blood Cancer UK: Hopes for our community’s future in the time of COVID

This thought leadership series has been paid and developed by Kite, a Gilead Company. This Blood Cancer Awareness Month, Blood Cancer UK’s Kate Keightley explains the need for better awareness and understanding of this common, but less-understood disease. Blood cancer is the fifth most common cancer in the UK and the third most deadly, killing …

Blood Cancer UK: Hopes for our community’s future in the time of COVID Read More »

Sleepless Nights For Evolutionary Biologists: A Greek Tragedy in The Making

By MIKE MAGEE In my Jesuit high school, we were offered only one science course – chemistry. I took it in my Senior year and did pretty well. In contrast, I took four years of Latin, and three years of Greek, as part of the school’s Greek Honors tract. Little did I know that Covid …

Sleepless Nights For Evolutionary Biologists: A Greek Tragedy in The Making Read More »

Cancer research faces uncertain post-COVID landscape

There’s a bright future ahead for cancer research in the UK, but only if the government is able to implement a clear plan for funding and development going forward, says The Institute of Cancer Research, London’s Paul Workman. Cancer research in the UK risks facing a “perfect storm” of stalled work and reduced funding that …

Cancer research faces uncertain post-COVID landscape Read More »

Oncology and a year of COVID: lessons for the future

COVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up opportunities to take learnings and create long-lasting change in research, practice and education, says Lucid’s Frances O’Connor. The COVID-19 pandemic might finally be in its latter stages after a year and a half of disruption, but its …

Oncology and a year of COVID: lessons for the future Read More »

How hybrid virtual engagement is accelerating oncology communication

COVID has revolutionised the way pharma engages with healthcare stakeholders – but to be truly successful, digital engagement needs to move away from an overreliance on real-time meetings, say experts from Within3. By making virtual meetings a necessity, COVID has forced pharma to adopt a more flexible, digitally-driven approach to stakeholder interaction – but in …

How hybrid virtual engagement is accelerating oncology communication Read More »

Why pharma shouldn’t forget about sites in a post-COVID world

The pandemic forced massive changes to oncology sites to ensure patient safety and research continuity – but we must recalibrate and work with sites to understand the value proposition of the technologies and methodologies adopted, says Syneos Health’s Angela Hirst. Formerly an oncology nurse and now director of Sites and Patient Services at Syneos Health’s …

Why pharma shouldn’t forget about sites in a post-COVID world Read More »

COVID-19 public health emergency waiver flexibilities and the path to reducing regulatory burden

In November 2020, the Department of Health and Human Services (HHS) released two requests for information (RFIs), seeking input from stakeholders on reducing regulatory burden and regulatory relief that could support economic recovery. A significant focus in one of the RFIs is to consider the costs and benefits of retaining particular regulatory changes beyond the

Keeping clinical trial data safe – handling cybersecurity in a risky world

The development of vaccines for COVID-19 has been a masterclass in effective collaboration and applied digitisation in healthcare. However the increased complexity and involvement of different parties, exposes manufacturers to heightened threat levels. Abel Archundia discusses how COVID-19 has highlighted the importance of securing clinical trials against cyber threats. A process that historically would have …

Keeping clinical trial data safe – handling cybersecurity in a risky world Read More »

Inside the UK’s leading efforts to restart clinical research

A herculean national effort has seen 69% of paused studies due to COVID restarted under the National Institute for Health Research’s (NIHR) Restart Framework. Experts from the institute tell us how those numbers can be further boosted, and how lessons learned from the sector-wide collaboration will change UK research forever. There has been a remarkable …

Inside the UK’s leading efforts to restart clinical research Read More »

Pfizer files tick-borne encephalitis shot with FDA

Pfizer may have been making headlines with the COVID vaccine it developed with BioNTech, but it’s not the only infectious disease the big pharma is targeting. In a statement, Pfizer said the FDA has granted a fast review for TicoVac tick-borne encephalitis (TBE) vaccine, to prevent the disease in individuals one year of age or …

Pfizer files tick-borne encephalitis shot with FDA Read More »

Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone

Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio Buyout Horizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion to augment its portfolio and pipeline of treatments for rare diseases. The shares of Viela Bio skyrocketed more than 52% in premarket trading after the news was broadcasted.  The deal …

Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone Read More »

Digital therapeutics: Why human psychology is key to adoption

The healthcare system is running at its limits in many countries worldwide. One reason is the growing demand for healthcare, largely driven by the rise of chronic diseases. COVID-19 has further underscored just how stretched the system is today. Is there any solution to the twin challenge of managing costs while extending capacity? We believe …

Digital therapeutics: Why human psychology is key to adoption Read More »

ISPOR Europe Panel: “Will COVID-19 Accelerate the Adoption of Digital Health Technologies?”

Tomorrow, Monday, November 16 at 15:00 CET (9:00 EST/6:00 PST), I will be on an ISPOR Europe Panel titled “Will COVID-19 Accelerate the Adoption of Digital Health Technologies? Perspectives on Evaluating Digital Health Technologies during Global Disease Outbreaks“. The session will be moderated by Kristian Kidholm, PhD of the University of Southern Denmark, and my …

ISPOR Europe Panel: “Will COVID-19 Accelerate the Adoption of Digital Health Technologies?” Read More »

Novartis’s Spartalizumab Combo Stubles; Union Therapeutics Doses In COVID-19 Trial; Yumanity To Merge With Proteostasis

Novartis’s Spartalizumab Combo Fails To Meet The Primary Goal In The Melanoma Trial  Novartis recently declared the results of its Phase III COMBI-I trial evaluating its experimental checkpoint inhibitor spartalizumab in combination with Tafinlar (dabrafenib) and Mekinist (trametinib) for patients, previously untreated, with unresectable or metastatic BRAF V600 mutation-positive melanoma compared to Tafinlar and Mekinist …

Novartis’s Spartalizumab Combo Stubles; Union Therapeutics Doses In COVID-19 Trial; Yumanity To Merge With Proteostasis Read More »

[Podcast] How Cleveland Clinic Helps Employers Create a Safer Workplace During COVID-19

Dr. Jim Merlino, Chief Clinical Transformation Officer, Cleveland Clinic Despite having entered the US eight months ago, COVID-19 remains a topic enshrouded in confusion, conflicting information, hyperbole, and even conspiracy theories. Everyone, informed or not, seems to have an opinion about the coronavirus pandemic. Fortunately, health systems, hospitals, and medical providers are  uniquely qualified to …

[Podcast] How Cleveland Clinic Helps Employers Create a Safer Workplace During COVID-19 Read More »

California School Districts Grope for Sensible Reopening Plans

School leaders in Elk Grove, California, wanted to leave as little to chance as possible. So they brought nearly 150 voices into their decision-making process, and canvassed the parents of the estimated 63,000 students in the district to ask how they wanted their children taught. The result was a four-item menu of instruction choices for …

California School Districts Grope for Sensible Reopening Plans Read More »

Next Showdown in Congress: Protecting Workers vs. Protecting Employers in the Pandemic

Congressional leaders are squaring off over the next pandemic relief bill in a debate over whom Congress should step up to protect: front-line workers seeking more safeguards from the ravages of COVID-19 or beleaguered employers seeking relief from lawsuits. Democrats want to enact an emergency standard meant to bolster access to protective gear for health …

Next Showdown in Congress: Protecting Workers vs. Protecting Employers in the Pandemic Read More »

[Podcast] How to Adjust Your Creative Strategies In Response to the COVID-19 Pandemic?

Dana Callow, Executive Creative Director, Healthcare Success COVID-19 has been a life-changing event for us all. It’s the kind of event that has lasting effects on people that we can’t even truly see just yet. We’ve thrust an entire population into a cycle of grief that is ubiquitous but unique to every person. How will …

[Podcast] How to Adjust Your Creative Strategies In Response to the COVID-19 Pandemic? Read More »

How Are Healthcare Consumers Responding to the Coronavirus Pandemic?

COVID-19: The New Normal for Healthcare Consumers A “new normal” is emerging in healthcare for both providers and patients. Healthcare industry leaders and medical marketing professionals constantly struggle to keep pace with changes. We all have the challenge of adjusting to pandemic demands and shifting consumer attitudes. Some questions are emerging: What do healthcare patients …

How Are Healthcare Consumers Responding to the Coronavirus Pandemic? Read More »

Key learnings for the intersection between PDGM and COVID-19 (webinar)

In a world jam-packed with COVID-19 information and communications, home health centers are looking for direction. Not only are they adapting to PDGM—the most significant change to Medicare’s payment methodology for home health services in nearly 20 years—but they are also facing strong headwinds from the unprecedented crisis, COVID-19. It’s a perfect storm.

When to Wear Gloves To Prevent COVID-19?

Gloves form an essential part of the personal protective equipment (PPE). However, unlike masks, gloves are not supposed to be worn all the time or when outdoors to buy groceries. As per the U.S. Centers for Disease Control and Prevention (CDC), gloves should be worn under two circumstances: When caring for the sick Gloves should …

When to Wear Gloves To Prevent COVID-19? Read More »

Vein Practice Marketing Strategies to Implement Now

Marketing Strategies to Implement Now For Your Vein Practice A Webinar Sponsored by the American Vein and Lymphatic Society COVID-19 has caused massive economic disruption to virtually every kind of business, including vein practices. Which marketing strategies should you begin now, and which should you implement in the coming months as the crisis slowly subsides? …

Vein Practice Marketing Strategies to Implement Now Read More »

Telemedicine & Telehealth Emerge as Medical Marketing Opportunities During COVID

March 17, 2020, may well be remembered as the day the telemedicine revolution finally took off. Telemedicine and Telehealth‘s adoption, fast-tracked by Coronavirus/COVID, will create profound changes in how healthcare services are provided — while also spawning new healthcare marketing opportunities. Telemedicine & Telehealth: Innovation & Opportunities Earlier last month, in the interest of public safety, …

Telemedicine & Telehealth Emerge as Medical Marketing Opportunities During COVID

Read More »

COVID Healthcare Marketing Questions: Pause, Pivot, or Push Forward

COVID Healthcare Marketing Webinar COVID-19 has changed the healthcare industry quicker in the last two weeks than in the last 50 years. With medical practices temporarily shutting down and elective procedures put on hold, what should healthcare networks and healthcare specialists do with their marketing campaigns‘ strategies? Stewart Gandolf, CEO, Healthcare Success Aaron Clifford, SVP …

COVID Healthcare Marketing Questions: Pause, Pivot, or Push Forward Read More »